Company intelligence / Profile preview
Guangzhou Baiyunshan Zhongyi Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guangzhou Baiyunshan Zhongyi Pharmaceutical is a leading Chinese pharmaceutical manufacturer specializing in traditional Chinese medicines with a growing portfolio of chemical drugs. Its flagship TCMs are approved and widely used across China. The company has also developed generic small molecules including antibiotics that have reached commercial stage. Select innovative programs are advancing through clinical trials—most notably an oncology asset targeting RET currently at Phase 2.
- Therapeutic areas
- NeurologyPulmonologyInfectious DiseasesEndocrinologyOncologyWomen's Health
- Modalities
- Herbal medicineSmall moleculeBiologic
- Industry
- Biotech
Drug pipeline
11 assets10 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Guangzhou Baiyunshan Zhongyi Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Baiyunshan Zhongyi Pharmaceutical.